0000899243-22-029203.txt : 20220818
0000899243-22-029203.hdr.sgml : 20220818
20220818184350
ACCESSION NUMBER: 0000899243-22-029203
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220818
DATE AS OF CHANGE: 20220818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Robin L
CENTRAL INDEX KEY: 0001365035
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38914
FILM NUMBER: 221178484
MAIL ADDRESS:
STREET 1: C/O PHASE III MEDICAL, INC.
STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120
CITY: MELVILLE
STATE: NY
ZIP: 11747
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celularity Inc
CENTRAL INDEX KEY: 0001752828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831702591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (908) 768-2170
MAIL ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: GX Acquisition Corp.
DATE OF NAME CHANGE: 20180912
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-16
0
0001752828
Celularity Inc
CELU
0001365035
Smith Robin L
C/O CELULARITY INC.
170 PARK AVENUE
FLORHAM PARK
NJ
07932
1
0
0
0
Stock Option (Right to Buy)
2.99
2022-08-16
4
A
0
250000
0.00
A
2032-08-16
Class A Common Stock
250000
250000
D
Stock Option (Right to Buy)
2.99
2022-08-16
4
A
0
800000
0.00
A
2032-08-16
Class A Common Stock
800000
800000
D
This option vested and became exercisable immediately on the grant date.
This option is subject to vesting in four equal tranches, based on achievement of certain pre-defined performance targets, and subject to the Reporting Person's continuous service with the Issuer through each such date.
/s/ Kyle Fletcher, Attorney-in-Fact
2022-08-18